XORTX THERAPEUTICS INC (XRTX:NASDAQ)
$2.44 0.28 (12.963%)
Analysed XORTX THERAPEUTICS INC (XRTX:NASDAQ) News Sources
XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset
13-04-2026
yahoo.com
XORTX Confirms Effective Date of Share Consolidation
01-04-2026
yahoo.com
XORTX Announces Results of Annual and Special Meeting of Shareholders
26-03-2026
yahoo.com
XORTX Announces Change of Effective Date of Share Consolidation
26-03-2026
yahoo.com
XORTX Announces Share Consolidation
25-03-2026
yahoo.com
XORTX Reports that Shareholders Approved the Share Consolidation at the Annual General Meeting
24-03-2026
yahoo.com
XORTX Announces Substitute Director Nominees for its Upcoming Annual and Special Meeting of Shareholders
18-03-2026
yahoo.com
XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote “For” the Share Consolidation
13-03-2026
yahoo.com
XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders
05-03-2026
yahoo.com
XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
04-02-2026
yahoo.com
What is the current price of XORTX THERAPEUTICS INC (XRTX:NASDAQ)?
The current price of XORTX THERAPEUTICS INC (XRTX:NASDAQ) is $2.44.
XORTX THERAPEUTICS INC (XRTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of XORTX THERAPEUTICS INC (XRTX:NASDAQ) since the previous trading day is $0.28.
XORTX THERAPEUTICS INC (XRTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of XORTX THERAPEUTICS INC (XRTX:NASDAQ) since the previous trading day is 12.963%.
What is the most recent average sentiment score for XORTX THERAPEUTICS INC (XRTX:NASDAQ)?
The most recent average sentiment score for XORTX THERAPEUTICS INC (XRTX:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for XORTX THERAPEUTICS INC (XRTX:NASDAQ)?
The most recent sentiment for XORTX THERAPEUTICS INC (XRTX:NASDAQ) is .
SEC-8K** Filing Available For XORTX THERAPEUTICS INC (XRTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.